Evidence map›Paper›PMID 26987796›Full record

ArticleScientific reports2016

The nematode Caenorhabditis elegans as a tool to predict chemical activity on mammalian development and identify mechanisms influencing toxicological outcome.

Philippa H Harlow, Simon J Perry, Stephanie Widdison, Shannon Daniels, Eddie Bondo, Clemens Lamberth, Richard A Currie, Anthony J Flemming

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Quantifying Embryonic Lethality Rate in Caenorhabditis elegans.Journal of visualized experiments : JoVE · 2026
    Article
  5. Article
  6. TheToxicology reports · 2025
    Article
  7. Article
  8. Sublethal Concentrations of 2C-I and 25I-NBOMe Designer Drugs ImpactInternational journal of molecular sciences · 2025
    Article
  9. Article
  10. Screening for toxicity of azole fungicides inmicroPublication biology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Acute, Sublethal, and Developmental Toxicity of Kratom (International journal of environmental research and public health · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Philippa H HarlowSyngenta Ltd., Jealott's Hill Research Station, Bracknell, Berkshire, RG42 6EY, UK.
Simon J PerrySyngenta Ltd., Jealott's Hill Research Station, Bracknell, Berkshire, RG42 6EY, UK.
Stephanie WiddisonGeneral Bioinformatics, Jealott's Hill Research Station, Bracknell, Berkshire, RG42 6EY, UK.
Shannon DanielsSyngenta, 3054 East Cornwallis Road, Research Triangle Park, NC 27709-2257, USA.
Eddie BondoSyngenta, 3054 East Cornwallis Road, Research Triangle Park, NC 27709-2257, USA.
Clemens LamberthSyngenta Crop Protection AG, Chemical Research, Schaffhauserstrasse 101, 4332 Stein, Switzerland.
Richard A CurrieSyngenta Ltd., Jealott's Hill Research Station, Bracknell, Berkshire, RG42 6EY, UK.
Anthony J FlemmingSyngenta Ltd., Jealott's Hill Research Station, Bracknell, Berkshire, RG42 6EY, UK.

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
NIH HHS P40 OD010440
6 · The paper itself

Abstract

To determine whether a C. elegans bioassay could predict mammalian developmental activity, we selected diverse compounds known and known not to elicit such activity and measured their effect on C. elegans egg viability. 89% of compounds that reduced C. elegans egg viability also had mammalian developmental activity. Conversely only 25% of compounds found not to reduce egg viability in C. elegans were also inactive in mammals. We conclude that the C. elegans egg viability assay is an accurate positive predictor, but an inaccurate negative predictor, of mammalian developmental activity. We then evaluated C. elegans as a tool to identify mechanisms affecting toxicological outcomes among related compounds. The difference in developmental activity of structurally related fungicides in C. elegans correlated with their rate of metabolism. Knockdown of the cytochrome P450s cyp-35A3 and cyp-35A4 increased the toxicity to C. elegans of the least developmentally active compounds to the level of the most developmentally active. This indicated that these P450s were involved in the greater rate of metabolism of the less toxic of these compounds. We conclude that C. elegans based approaches can predict mammalian developmental activity and can yield plausible hypotheses for factors affecting the biological potency of compounds in mammals.

Indexed as

AnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsCytochrome P-450 Enzyme SystemGene Knockout TechniquesHumansMammalsModels, AnimalPesticidesStructure-Activity RelationshipToxicity TestsCaenorhabditis elegans ProteinsCytochrome P-450 Enzyme SystemPesticides

Identifiers

PMID26987796
PMCPMC4796825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.